Munich, Georgia

Peter Heilmann


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Peter Heilmann in Solid Dosage Forms

Introduction

Peter Heilmann is an accomplished inventor based in Munich, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid dosage forms. His innovative approach focuses on enhancing the effectiveness of active substances through advanced film technology.

Latest Patents

Peter Heilmann holds a patent for a solid dosage form with a film containing an active substance, as well as its method of production. The patent describes a solid dosage form that includes at least one film, which contains an active substance in sections. Notably, the concentration of the active substance in the film exhibits a gradient in a direction normal to the thickness of the film. This invention also outlines a method for producing such a solid dosage form, emphasizing the gradient concentration in the longitudinal direction of the film.

Career Highlights

Heilmann is currently associated with AbbVie Deutschland GmbH & Co. KG, where he continues to work on innovative pharmaceutical solutions. His expertise in solid dosage forms has positioned him as a key player in the industry, contributing to advancements that improve patient outcomes.

Collaborations

Throughout his career, Peter Heilmann has collaborated with notable colleagues, including Jörg Rosenberg and Jörg Breitenbach. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Peter Heilmann's work in the field of solid dosage forms exemplifies the impact of innovation in pharmaceuticals. His patented technology not only enhances the delivery of active substances but also showcases the importance of research and development in improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…